Alaunos Therapeutics logo

Alaunos TherapeuticsNASDAQ: TCRT

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

24 August 2005

Next earnings report:

09 May 2025

Last dividends:

N/A

Next dividends:

N/A
$3.39 M
-99%vs. 3y high
10%vs. sector
-vs. 3y high
-vs. sector
-93%vs. 3y high
45%vs. sector
-vs. 3y high
-vs. sector

Price

after hours | Tue, 19 Nov 2024 22:52:23 GMT
$2.12-$0.05(-2.30%)

Dividend

No data over the past 3 years

Analysts recommendations

Institutional Ownership

TCRT Latest News

Alaunos (TCRT) to Wind Down Sole Clinical Study, Stock Dips 65%
Zacks Investment Research16 August 2023 Sentiment: NEGATIVE

Due to a lack of funding needs, Alaunos (TCRT) decides to end its only clinical study. The company will instead focus on its hunTR TCR discovery platform and explore broad strategic alternatives.

Alaunos Therapeutics to Participate in Upcoming Investor Conferences in April
GlobeNewsWire29 March 2023 Sentiment: POSITIVE

HOUSTON, March 29, 2023 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a leading T-cell receptor (TCR) cell therapy company advancing a clinical-stage pipeline of therapeutics for solid tumors, today announced that company management will be participating in the following upcoming investor conferences.

What type of business is Alaunos Therapeutics?

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive T-cell receptor (TCR) engineered T-cell therapies (TCR-T) to treat multiple solid tumor types. It develops Library TCR-T Cell Theraphy, which is in Phase I/II clinical trial for 12 TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. The company is also developing hunTR, a human neoantigen TCR discovery engine; and Sleeping Beauty Gene Transfer Platform, a non-viral genetic engineering technology. The company was founded in 2003 and is headquartered in Houston, Texas.

What sector is Alaunos Therapeutics in?

Alaunos Therapeutics is in the Healthcare sector

What industry is Alaunos Therapeutics in?

Alaunos Therapeutics is in the Biotechnology industry

What country is Alaunos Therapeutics from?

Alaunos Therapeutics is headquartered in United States

When did Alaunos Therapeutics go public?

Alaunos Therapeutics initial public offering (IPO) was on 24 August 2005

What is Alaunos Therapeutics website?

https://www.alaunos.com

Is Alaunos Therapeutics in the S&P 500?

No, Alaunos Therapeutics is not included in the S&P 500 index

Is Alaunos Therapeutics in the NASDAQ 100?

No, Alaunos Therapeutics is not included in the NASDAQ 100 index

Is Alaunos Therapeutics in the Dow Jones?

No, Alaunos Therapeutics is not included in the Dow Jones index

When was Alaunos Therapeutics the previous earnings report?

No data

When does Alaunos Therapeutics earnings report?

The next expected earnings date for Alaunos Therapeutics is 09 May 2025